S. C. Atalar, "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era," BLOOD , vol.140, pp.9554-9556, 2022
Atalar, S. C. 2022. Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era. BLOOD , vol.140 , 9554-9556.
Atalar, S. C., (2022). Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era. BLOOD , vol.140, 9554-9556.
Atalar, Semra. "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era," BLOOD , vol.140, 9554-9556, 2022
Atalar, Semra C. . "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era." BLOOD , vol.140, pp.9554-9556, 2022
Atalar, S. C. (2022) . "Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era." BLOOD , vol.140, pp.9554-9556.
@article{article, author={Semra Cemre ATALAR}, title={Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era}, journal={BLOOD}, year=2022, pages={9554-9556} }